Moreover, Talvio et al. (47) reported a decrease of ATP-binding cassette transporter A1 (ABCA1) (cholesterol membrane transporter to the extracellular environment) in both human and mouse iPSC-derived astrocyte model of FXS. This evidence concerns the gene ABCA1 and fragile X syndrome.